nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.506	1	CbGbCtD
Clopidogrel—Iron deficiency anaemia—Riluzole—amyotrophic lateral sclerosis	0.0243	0.0534	CcSEcCtD
Clopidogrel—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0326	CcSEcCtD
Clopidogrel—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0326	CcSEcCtD
Clopidogrel—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0313	CcSEcCtD
Clopidogrel—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0259	CcSEcCtD
Clopidogrel—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00997	0.0219	CcSEcCtD
Clopidogrel—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0095	0.0209	CcSEcCtD
Clopidogrel—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00928	0.0204	CcSEcCtD
Clopidogrel—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00928	0.0204	CcSEcCtD
Clopidogrel—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00802	0.0176	CcSEcCtD
Clopidogrel—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0171	CcSEcCtD
Clopidogrel—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0164	CcSEcCtD
Clopidogrel—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0156	CcSEcCtD
Clopidogrel—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00656	0.0144	CcSEcCtD
Clopidogrel—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0134	CcSEcCtD
Clopidogrel—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00607	0.0133	CcSEcCtD
Clopidogrel—Gout—Riluzole—amyotrophic lateral sclerosis	0.00591	0.013	CcSEcCtD
Clopidogrel—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0128	CcSEcCtD
Clopidogrel—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0128	CcSEcCtD
Clopidogrel—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0058	0.0127	CcSEcCtD
Clopidogrel—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00552	0.0121	CcSEcCtD
Clopidogrel—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00524	0.0115	CcSEcCtD
Clopidogrel—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0114	CcSEcCtD
Clopidogrel—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0111	CcSEcCtD
Clopidogrel—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00499	0.011	CcSEcCtD
Clopidogrel—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00459	0.0101	CcSEcCtD
Clopidogrel—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00984	CcSEcCtD
Clopidogrel—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00984	CcSEcCtD
Clopidogrel—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0098	CcSEcCtD
Clopidogrel—Injury—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00958	CcSEcCtD
Clopidogrel—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00913	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00414	0.0091	CcSEcCtD
Clopidogrel—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00906	CcSEcCtD
Clopidogrel—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00902	CcSEcCtD
Clopidogrel—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0088	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0088	CcSEcCtD
Clopidogrel—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00813	CcSEcCtD
Clopidogrel—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00779	CcSEcCtD
Clopidogrel—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00766	CcSEcCtD
Clopidogrel—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00761	CcSEcCtD
Clopidogrel—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00746	CcSEcCtD
Clopidogrel—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00741	CcSEcCtD
Clopidogrel—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00732	CcSEcCtD
Clopidogrel—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00723	CcSEcCtD
Clopidogrel—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00712	CcSEcCtD
Clopidogrel—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00682	CcSEcCtD
Clopidogrel—Depression—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00677	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00665	CcSEcCtD
Clopidogrel—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00661	CcSEcCtD
Clopidogrel—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.003	0.0066	CcSEcCtD
Clopidogrel—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00647	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00642	CcSEcCtD
Clopidogrel—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0064	CcSEcCtD
Clopidogrel—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00637	CcSEcCtD
Clopidogrel—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00633	CcSEcCtD
Clopidogrel—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00612	CcSEcCtD
Clopidogrel—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00611	CcSEcCtD
Clopidogrel—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00609	CcSEcCtD
Clopidogrel—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00609	CcSEcCtD
Clopidogrel—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00606	CcSEcCtD
Clopidogrel—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00606	CcSEcCtD
Clopidogrel—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00602	CcSEcCtD
Clopidogrel—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00273	0.006	CcSEcCtD
Clopidogrel—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00597	CcSEcCtD
Clopidogrel—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00576	CcSEcCtD
Clopidogrel—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00569	CcSEcCtD
Clopidogrel—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00553	CcSEcCtD
Clopidogrel—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0055	CcSEcCtD
Clopidogrel—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00549	CcSEcCtD
Clopidogrel—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00534	CcSEcCtD
Clopidogrel—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00241	0.0053	CcSEcCtD
Clopidogrel—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00522	CcSEcCtD
Clopidogrel—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00513	CcSEcCtD
Clopidogrel—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0051	CcSEcCtD
Clopidogrel—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0049	CcSEcCtD
Clopidogrel—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00484	CcSEcCtD
Clopidogrel—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00476	CcSEcCtD
Clopidogrel—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00475	CcSEcCtD
Clopidogrel—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00475	CcSEcCtD
Clopidogrel—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00469	CcSEcCtD
Clopidogrel—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00466	CcSEcCtD
Clopidogrel—Cough—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00463	CcSEcCtD
Clopidogrel—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00458	CcSEcCtD
Clopidogrel—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00451	CcSEcCtD
Clopidogrel—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00451	CcSEcCtD
Clopidogrel—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00451	CcSEcCtD
Clopidogrel—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0045	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00448	CcSEcCtD
Clopidogrel—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00436	CcSEcCtD
Clopidogrel—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00433	CcSEcCtD
Clopidogrel—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00433	CcSEcCtD
Clopidogrel—Infection—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0043	CcSEcCtD
Clopidogrel—Shock—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00426	CcSEcCtD
Clopidogrel—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00424	CcSEcCtD
Clopidogrel—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0042	CcSEcCtD
Clopidogrel—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00404	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00394	CcSEcCtD
Clopidogrel—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00391	CcSEcCtD
Clopidogrel—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00389	CcSEcCtD
Clopidogrel—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00386	CcSEcCtD
Clopidogrel—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00381	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00374	CcSEcCtD
Clopidogrel—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00373	CcSEcCtD
Clopidogrel—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0037	CcSEcCtD
Clopidogrel—Pain—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0037	CcSEcCtD
Clopidogrel—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00357	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00354	CcSEcCtD
Clopidogrel—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00344	CcSEcCtD
Clopidogrel—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00342	CcSEcCtD
Clopidogrel—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00342	CcSEcCtD
Clopidogrel—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00319	CcSEcCtD
Clopidogrel—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0031	CcSEcCtD
Clopidogrel—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00306	CcSEcCtD
Clopidogrel—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00296	CcSEcCtD
Clopidogrel—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00286	CcSEcCtD
Clopidogrel—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00275	CcSEcCtD
Clopidogrel—Rash—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00273	CcSEcCtD
Clopidogrel—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00273	CcSEcCtD
Clopidogrel—Headache—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00271	CcSEcCtD
Clopidogrel—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00257	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000574	0.0147	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000572	0.0146	CbGpPWpGaD
Clopidogrel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000558	0.0143	CbGpPWpGaD
Clopidogrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000521	0.0133	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000517	0.0132	CbGpPWpGaD
Clopidogrel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000445	0.0114	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000441	0.0113	CbGpPWpGaD
Clopidogrel—P2RY12—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000432	0.0111	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000427	0.0109	CbGpPWpGaD
Clopidogrel—CES1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00035	0.00895	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000345	0.00883	CbGpPWpGaD
Clopidogrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000344	0.0088	CbGpPWpGaD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000343	0.00879	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000296	0.00757	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000275	0.00704	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000266	0.00682	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000261	0.00669	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00025	0.00639	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000224	0.00574	CbGpPWpGaD
Clopidogrel—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000208	0.00534	CbGpPWpGaD
Clopidogrel—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000196	0.00503	CbGpPWpGaD
Clopidogrel—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000192	0.00491	CbGpPWpGaD
Clopidogrel—P2RY12—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000188	0.00483	CbGpPWpGaD
Clopidogrel—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000184	0.0047	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000172	0.0044	CbGpPWpGaD
Clopidogrel—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000166	0.00425	CbGpPWpGaD
Clopidogrel—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000164	0.0042	CbGpPWpGaD
Clopidogrel—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000162	0.00416	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000152	0.0039	CbGpPWpGaD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00015	0.00384	CbGpPWpGaD
Clopidogrel—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000149	0.00383	CbGpPWpGaD
Clopidogrel—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000148	0.0038	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000148	0.00378	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00014	0.00359	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000138	0.00353	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000135	0.00346	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000134	0.00344	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000129	0.0033	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000128	0.00328	CbGpPWpGaD
Clopidogrel—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000128	0.00327	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000117	0.003	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000116	0.00296	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.00296	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000114	0.00292	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000114	0.00292	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000111	0.00284	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000109	0.00279	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000105	0.00268	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000104	0.00267	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000104	0.00267	CbGpPWpGaD
Clopidogrel—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000104	0.00265	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000102	0.00262	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	9.95e-05	0.00255	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.83e-05	0.00252	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	9.8e-05	0.00251	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.71e-05	0.00249	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	9.64e-05	0.00247	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.52e-05	0.00244	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	9.36e-05	0.0024	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.32e-05	0.00239	CbGpPWpGaD
Clopidogrel—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.24e-05	0.00237	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.13e-05	0.00234	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.03e-05	0.00231	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.92e-05	0.00228	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.9e-05	0.00228	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.85e-05	0.00227	CbGpPWpGaD
Clopidogrel—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	8.84e-05	0.00226	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	8.81e-05	0.00225	CbGpPWpGaD
Clopidogrel—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.78e-05	0.00225	CbGpPWpGaD
Clopidogrel—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.66e-05	0.00222	CbGpPWpGaD
Clopidogrel—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.59e-05	0.0022	CbGpPWpGaD
Clopidogrel—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.47e-05	0.00217	CbGpPWpGaD
Clopidogrel—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.42e-05	0.00216	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.33e-05	0.00213	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.14e-05	0.00208	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	8.03e-05	0.00206	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.02e-05	0.00205	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.93e-05	0.00203	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.85e-05	0.00201	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	7.7e-05	0.00197	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.57e-05	0.00194	CbGpPWpGaD
Clopidogrel—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.44e-05	0.0019	CbGpPWpGaD
Clopidogrel—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.33e-05	0.00188	CbGpPWpGaD
Clopidogrel—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.2e-05	0.00184	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.11e-05	0.00182	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.01e-05	0.0018	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	6.8e-05	0.00174	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.73e-05	0.00172	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.73e-05	0.00172	CbGpPWpGaD
Clopidogrel—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.64e-05	0.0017	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.63e-05	0.0017	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	6.58e-05	0.00168	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	6.58e-05	0.00168	CbGpPWpGaD
Clopidogrel—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.55e-05	0.00168	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.45e-05	0.00165	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.26e-05	0.0016	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.16e-05	0.00158	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	6.06e-05	0.00155	CbGpPWpGaD
Clopidogrel—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.05e-05	0.00155	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	6.02e-05	0.00154	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.97e-05	0.00153	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.86e-05	0.0015	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	5.81e-05	0.00149	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	5.73e-05	0.00147	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.72e-05	0.00147	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.71e-05	0.00146	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	5.7e-05	0.00146	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	5.7e-05	0.00146	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	5.69e-05	0.00146	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.59e-05	0.00143	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	5.47e-05	0.0014	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.45e-05	0.00139	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.38e-05	0.00138	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.31e-05	0.00136	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	5.26e-05	0.00135	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	5.21e-05	0.00133	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.18e-05	0.00133	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.17e-05	0.00132	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.13e-05	0.00131	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.11e-05	0.00131	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.1e-05	0.00131	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	5.09e-05	0.0013	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	5.09e-05	0.0013	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.96e-05	0.00127	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.96e-05	0.00127	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	4.93e-05	0.00126	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.88e-05	0.00125	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	4.87e-05	0.00125	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.86e-05	0.00125	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.85e-05	0.00124	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	4.76e-05	0.00122	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.74e-05	0.00121	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	4.65e-05	0.00119	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.64e-05	0.00119	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.64e-05	0.00119	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	4.56e-05	0.00117	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.54e-05	0.00116	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.4e-05	0.00113	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.4e-05	0.00113	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.32e-05	0.00111	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.32e-05	0.00111	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.24e-05	0.00109	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.22e-05	0.00108	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.16e-05	0.00107	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	4.12e-05	0.00105	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.07e-05	0.00104	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.99e-05	0.00102	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.97e-05	0.00102	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.96e-05	0.00101	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.96e-05	0.00101	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.94e-05	0.00101	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.94e-05	0.00101	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.92e-05	0.001	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.91e-05	0.001	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—amyotrophic lateral sclerosis	3.87e-05	0.000992	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.72e-05	0.000953	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.71e-05	0.000949	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.7e-05	0.000946	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.69e-05	0.000944	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	3.68e-05	0.000942	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.62e-05	0.000928	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	3.6e-05	0.000923	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	3.59e-05	0.000919	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.46e-05	0.000886	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	3.4e-05	0.000871	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.37e-05	0.000863	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.35e-05	0.000859	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	3.33e-05	0.000852	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.22e-05	0.000825	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.17e-05	0.000811	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	3.12e-05	0.000799	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.09e-05	0.00079	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.06e-05	0.000783	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.06e-05	0.000783	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.88e-05	0.000738	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.87e-05	0.000734	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.87e-05	0.000734	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.8e-05	0.000716	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.79e-05	0.000716	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.79e-05	0.000714	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	2.73e-05	0.000699	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.72e-05	0.000696	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.66e-05	0.000681	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.62e-05	0.000672	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.6e-05	0.000666	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.57e-05	0.000659	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.54e-05	0.000651	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.51e-05	0.000643	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.45e-05	0.000626	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.43e-05	0.000623	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.37e-05	0.000606	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.35e-05	0.0006	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	0.0006	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.21e-05	0.000566	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.17e-05	0.000556	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.16e-05	0.000553	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.14e-05	0.000547	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.11e-05	0.000541	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.06e-05	0.000528	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.05e-05	0.000525	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2e-05	0.000513	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.94e-05	0.000496	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.93e-05	0.000493	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.93e-05	0.000493	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.84e-05	0.00047	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.83e-05	0.000467	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.76e-05	0.00045	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.74e-05	0.000445	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.68e-05	0.000429	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.65e-05	0.000421	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.55e-05	0.000396	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000385	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.5e-05	0.000384	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.48e-05	0.000379	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.47e-05	0.000376	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000353	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000345	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.32e-05	0.000338	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.31e-05	0.000336	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.000326	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.27e-05	0.000325	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.2e-05	0.000308	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000299	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000291	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.14e-05	0.000291	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.11e-05	0.000284	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.11e-05	0.000284	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000267	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	0.000265	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.03e-05	0.000263	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000261	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	9.62e-06	0.000246	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.51e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.84e-06	0.000226	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	8.58e-06	0.00022	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	8.38e-06	0.000214	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.13e-06	0.000208	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	7.83e-06	0.0002	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.78e-06	0.000199	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.61e-06	0.000195	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.83e-06	0.000175	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	6.69e-06	0.000171	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.59e-06	0.000169	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.27e-06	0.000161	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.88e-06	0.000151	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.74e-06	0.000147	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.36e-06	0.000137	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.16e-06	0.000132	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.58e-06	0.000117	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.54e-06	9.05e-05	CbGpPWpGaD
